4
Views
1
CrossRef citations to date
0
Altmetric
Articles

Decreased plasma adiponectin concentrations in patients with syndrome X

, MD, , MD, , MD, , MD, , MD, , MD & , MD show all
Pages 217-220 | Received 16 Oct 2009, Published online: 23 May 2017

References

  • Bugiardini R, Bairey Merz CN. Angina with “normal” coro-nary arteries: a changing philosophy. JAMA 2005; 293: 477–84.
  • Handberg E, Johnson BD, Arant CB, Wessel TR, Kerensky RA, von Mering G, Olson MB, Reis SE, Shaw L, Bairey Merz CN, Sharaf BL, Sopko G, Pepine CJ. Impaired coro-nary vascular reactivity and functional capacity in women: results from the NHLBI Women’s Ischemia Syndrome Eval-uation (WISE) Study. J Am Coll Cardiol 2006; 47(3 Suppl): S44–9.
  • Johnson BD, Shaw IA Buchthal SD, Bairey Merz CN, Kim HW, Scott KN, Doyle M, Olson MB, Pepine CJ, den Hol-lander J, Sharaf B, Rogers WJ, Mankad S, Forder JR, Kelsey SF, Pohost GM; National Institutes of Health-National Heart, Lung, and Blood Institute. National Institutes of Health - National Heart, Lung, and Blood Institute. Prog-nosis in women with myocardial ischemia in the absence of obstructive coronary disease: results from the National Institutes of Health - National Heart, Lung, and Blood Insti-tute-Sponsored Women’s Ischemia Syndrome Evaluation (WISE). Circulation 2004; 109: 2993–9.
  • Johnson BD, Shaw LI-, Pepine CJ, Reis SE, Kelsey SF, Sopko G, Rogers WJ, Mankad S, Sharaf BL, Bittner V, Bairey Merz CN. Persistent chest pain predicts cardiovascular events in women without obstructive coronary artery disease: results from the NTH-NHLBI-sponsored Women’s Ischaemia Syndrome Evaluation (WISE) study. Eur Heart J2006; 27: 1408–15.
  • Bajaj M, Suraamornkul S, Piper P, Hardies LJ, Glass L, Cersosimo E, Pratipanawatr T, Miyazaki Y, DeFronzo RA. Decreased plasma adiponectin concentrations are closely related to hepatic fat content and hepatic insulin resistance in pioglitazone-treated type 2 diabetic patients. J Clin Endocrinol Metab 2004; 89: 200–6.
  • Kasapis C, Thompson PD. The effects of physical activity on serum C-reactive protein and inflammatory markers: a systematic review. J Am Coll Cardiol 2005; 45: 1563–9.
  • Pischon T, Girman CJ, Hotamisligil GS, Rifai N, Hu FB, Rimm EB. Plasma adiponectin levels and risk of myocardial infarction in men. JAMA 2004; 291: 1730–7.
  • Kharroubi I, Rasschaert J, Eizirik DL, Cnop M. Expression of adiponectin receptors in pancreatic beta cells. Biochem Biophys Res Commun 2003; 312: 1118–22.
  • Chinetti G, Zawadski C, Fruchart JC, Staels B. Expression of adiponectin receptors in human macrophages and regu-lation by agonists of the nuclear receptors PPARalpha, PPARgamma, and LXR. Biochem Biophys Res Commun 2004; 314: 151–8.
  • Ouchi N, Ohishi M, Kihara S, Funahashi T, Nakamura T, Nagaretani H, Kumada M, Ohashi K, Okamoto Y, Nishizawa H, Kishida K, Maeda N, Nagasawa A, Kobayashi H, Hiraoka H, Komai N, Kaibe M, Rakugi H, Ogihara T, Matsuzawa Y Association of hypoadiponectinemia with impaired vasoreactivity. Hypertension 2003; 42: 231–4.
  • Ross R. Atherosclerosis-an inflammatory disease. N Engl J Med 1999; 340: 115–26.
  • Liischer TF. The endothelium and cardiovascular disease-a complex relation. N Engl J Med 1994; 330: 1081–3.
  • Maeda N, Shimomura I, Kishida K, Nishizawa H, MatsudaM, Nagaretani H, Matsuda M, Kondo H, Furuyama N, Kihara S, Nakamura T, Tochino Y, Funahashi T, Matsuzawa Y Diet-induced insulin resistance in mice lacking adipo-nectin/ACRP30. Nat Med 2002; 8: 731–7.
  • Libby P. Inflammation in atherosclerosis. Nature 2002; 420: 868–74.
  • Engeli S, Feldpausch M, Gorzelniak K, Hartwig F, Heintze U, Janke J, Möhlig M, Pfeiffer AF, Luft FC, Sharma AM. Association between adiponectin and mediators of inflam-mation in obese women. Diabetes 2003; 52: 942–7.
  • Ouchi N, Kihara S, Funahashi T, Nakamura T, Nishida M, Kumada M, Okamoto Y, Ohashi K, Nagaretani H, Kishida K, Nishizawa H, Maeda N, Kobayashi H, Hiraoka H, Matsuzawa Y Reciprocal association of C-reactive protein with adiponectin in blood stream and adipose tissue. Circu-lation 2003; 107: 671–4.
  • Krakoff J, Funahashi T, Stehouwer CD, Schalkwijk CG, Tanaka S, Matsuzawa Y, Kobes S, Tataranni PA, Hanson RL, Knowler WC, Lindsay RS. Inflammatory markers, adiponectin, and risk of type 2 diabetes in the Pima Indian. Diabetes Care 2003; 26: 1745–51.
  • Matsubara M, Namioka K, Katayose S. Decreased plasma adiponectin concentrations in women with low-grade C-reactive protein elevation. Eur J Endocrinol 2003; 148: 657–62.
  • Kern PA, Di Gregorio GB, Lu T, Rassouli N, Ranganathan G. Adiponectin expression from human adipose tissue: relation to obesity, insulin resistance, and tumor necrosis factor-alpha expression. Diabetes 2003; 52: 1779–85.
  • Berg AH, Scherer PE. Adipose tissue, inflammation, and cardiovascular disease. Circ Res 2005; 96: 939–49.
  • Chen H, Montaguani M, Funahashi T, Shimomura I, Quon MJ. Adiponectin stimulates production of nitric oxide in vascular endothelial cells. J Biol Chem 2003; 278: 45021–6.
  • Lau DC, Dhillon B, Yan H, Szmitko PE, Verma S. Adipokines: molecular links between obesity and athero-slcerosis. Am J Physiol Heart Circ Physiol 2005; 288: H2031–41.
  • Matsuda M, Shimomura I, Sata M, Arita Y, Nishida M, Maeda N, Kumada M, Okamoto Y, Nagaretani H, Nishizawa H, Kishida K, Komuro R, Ouchi N, Kihara S, Nagai R, Funahashi T, Matsuzawa Y Role of adiponectin in preventing vascular stenosis. The missing link of adipo-vascular axis. J Biol Chem 2002; 277: 37487-91S.
  • Ouchi N, Kihara S, Arita Y, Nishida M, Matsuyama A, Okamoto Y, Ishigami M, Kuriyama H, Kishida K, Nishizawa H, Hotta K, Muraguchi M, Ohmoto Y, Yamashita S, Funahashi T, Matsuzawa Y Adipocyte derived plasma protein, adiponectin, suppresses lipid accumulation and class A scavenger receptor expression in human mono-cyte-derived macrophages. Circulation 2001; 103: 1057–63.
  • Arita Y, Kihara S, Ouchi N, Maeda K, Kuriyama H, Okamoto Y, Kumada M, Hotta K, Nishida M, Takahashi M, Nakamura T, Shimomura I, Muraguchi M, Ohmoto Y, Funahashi T, Matsuzawa Y Adipocyte-derived plasma protein adiponectin acts as a platelet-derived growth factor-BB-binding protein and regulates growth factor-induced common postreceptor signal in vascular smooth muscle cell. Circulation 2002; 105: 2893–8.
  • Okamoto Y, Arita Y, Nishida M, Muraguchi M, Ouchi N, Takahashi M, Iwahashi H, Kuriyama H, Ouchi N, Maeda K, Nishida M, Kihara S, Sakai N, Nakajima T, Hasegawa K, Muraguchi M, Ohmoto Y, Nakamura T, Yamashita S. Hanafusa T, Matsuzawa Y An adipocyte-derived plasma protein, adiponectin, adheres to injured vascular walls. Horm Metab Res 2000; 32: 47–50.
  • Kumada M, Kihara S, Sumitsuji S, Kawamoto T, Mat-sumoto S, Ouchi N, Arita Y, Okamoto Y, Shimomura I, Hiraoka H, Nakamura T, Funahashi T, Matsuzawa Y; Osaka CAD Study Group. Coronary artery disease. Asso-ciation of hypoadiponectinemia with coronary artery dis-ease in men. Arterioscler Thromb Vasc Biol 2003; 23: 85–9.
  • Kubota N, Terauchi Y, Yamauchi T, Kubota T, Moroi M, Matsui J, Eto K, Yamashita T, Kamon J, Satoh H, Yano W, Froguel P, Nagai R, Kimura S, Kadowaki T, Noda T. Disruption of adiponectin causes insulin resistance and neointimal formation. J Biol Chem 2002; 277: 25863–6.
  • Koh KK, Quon MJ, Han SH, Chung WJ, Ahn JY, Seo YH, Kang MH, Alm TH, Choi IS, Shin EK. Additive beneficial effects of losartan combined with simvastatin in the treat-ment of hypercholesterolemic, hypertensive patients. Circu-lation 2004; 110: 3687–92.
  • Koh KK, Han SH, Quon MJ, Yeal Alm J, Shin EK. Bene-ficial effects of fenofibrate to improve endothelial dysfunc-tion and raise adiponectin levels in patients with primary hypertriglyceridemia. Diabetes Care 2005; 28: 1419–24.
  • Koh KK, Quon MJ, Han SH, Chung WJ, Alm JY, Kim JA, Lee Y, Shin EK. Additive beneficial effects of fenofibrate combined with candesartan in the treatment of hyper-triglyceridemic hypertensive patients. Diabetes Care 2006; 29: 195–201.
  • Pischon T, Hotamisligil GS, Rimm EB. Adiponectin: sta-bility in plasma over 36 hours and within-person variation over 1 year. Clin Chem 2003; 49: 650–2.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.